Author
Listed:
- Ashley D. Otter
(UK Health Security Agency, Porton Down)
- Scott Jones
(UK Health Security Agency, Porton Down)
- Bethany Hicks
(UK Health Security Agency, Porton Down)
- Daniel Bailey
(UK Health Security Agency, Porton Down)
- Helen Callaby
(UK Health Security Agency, Porton Down)
- Catherine Houlihan
(UK Health Security Agency, Porton Down
University College London)
- Tommy Rampling
(UK Health Security Agency, Porton Down
University College London Hospital
NIHR University College London Hospitals BRC)
- Nicola Claire Gordon
(UK Health Security Agency, Porton Down)
- Hannah Selman
(UK Health Security Agency, Porton Down)
- Panayampalli S. Satheshkumar
(Centre for Disease Control and Prevention)
- Michael Townsend
(Centre for Disease Control and Prevention)
- Ravi Mehta
(Imperial College Healthcare NHS Trust)
- Marcus Pond
(Imperial College Healthcare NHS Trust)
- Rachael Jones
(Chelsea and Westminster Hospital NHS Foundation Trust)
- Deborah Wright
(UK Health Security Agency, Porton Down)
- Clarissa Oeser
(UK Health Security Agency, Colindale)
- Simon Tonge
(UK Health Security Agency)
- Ezra Linley
(UK Health Security Agency)
- Georgia Hemingway
(UK Health Security Agency, Porton Down)
- Tom Coleman
(UK Health Security Agency, Porton Down)
- Sebastian Millward
(UK Health Security Agency, Porton Down)
- Aaron Lloyd
(UK Health Security Agency, Porton Down)
- Inger Damon
(Centre for Disease Control and Prevention)
- Tim Brooks
(UK Health Security Agency, Porton Down)
- Richard Vipond
(UK Health Security Agency, Porton Down)
- Cathy Rowe
(UK Health Security Agency, Porton Down)
- Bassam Hallis
(UK Health Security Agency, Porton Down)
Abstract
In early 2022, a cluster of monkeypox virus (MPXV) infection (mpox) cases were identified within the UK with no prior travel history to MPXV-endemic regions. Subsequently, case numbers exceeding 80,000 were reported worldwide, primarily affecting gay, bisexual, and other men who have sex with men (GBMSM). Public health agencies worldwide have offered the IMVANEX Smallpox vaccination to these individuals at high-risk to provide protection and limit the spread of MPXV. We have developed a comprehensive array of ELISAs to study poxvirus-induced antibodies, utilising 24 MPXV and 3 Vaccinia virus (VACV) recombinant antigens. Panels of serum samples from individuals with differing Smallpox-vaccine doses and those with prior MPXV infection were tested on these assays, where we observed that one dose of Smallpox vaccination induces a low number of antibodies to a limited number of MPXV antigens but increasing with further vaccination doses. MPXV infection induced similar antibody responses to diverse poxvirus antigens observed in Smallpox-vaccinated individuals. We identify MPXV A27 as a serological marker of MPXV-infection, whilst MPXV M1 (VACV L1) is likely IMVANEX-specific. Here, we demonstrate analogous humoral antigen recognition between both MPXV-infected or Smallpox-vaccinated individuals, with binding to diverse yet core set of poxvirus antigens, providing opportunities for future vaccine (e.g., mRNA) and therapeutic (e.g., mAbs) design.
Suggested Citation
Ashley D. Otter & Scott Jones & Bethany Hicks & Daniel Bailey & Helen Callaby & Catherine Houlihan & Tommy Rampling & Nicola Claire Gordon & Hannah Selman & Panayampalli S. Satheshkumar & Michael Town, 2023.
"Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals,"
Nature Communications, Nature, vol. 14(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41587-x
DOI: 10.1038/s41467-023-41587-x
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Weijie Yu & Xiaowen Zhang & Meijiao Du & Yue Dong & Lin Liu & Hongguo Rong & Jianping Liu, 2023.
"Bibliometric Analysis and Key Messages of Monkeypox Research (2003–2022),"
Sustainability, MDPI, vol. 15(2), pages 1-13, January.
- J Mauricio Calvo-Calle & Iwona Strug & Maria-Dorothea Nastke & Stephen P Baker & Lawrence J Stern, 2007.
"Human CD4+ T Cell Epitopes from Vaccinia Virus Induced by Vaccination or Infection,"
PLOS Pathogens, Public Library of Science, vol. 3(10), pages 1-19, October.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41587-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.